الاسم العلمي | الشكل الصيدلاني | التركيز |
---|---|---|
Live attenuated Rift Vally Fever strain clone 13T |
Lyophilisate and solvent for suspension for injection |
10 ^3.5log10 TCID50/dose |
Live attenuated Rift Vally Fever strain clone13t |
Lyophilisate and solvent for suspension for injection |
10^4.5log10 TCID50/dose |
Inactivated Newcastle disease virus strain NDV-SZ Lasota |
Emulsion for injection |
5 log2 HItitre |
Alpha toxoid of C perfringens type A/ Beta toxoid of C perfringens type C/ Epsilon toxoid of C perfringens type D/ Toxoid of C septicum/ Alpha toxoid of C novyi B/ Toxoid of C tetani/ Anaculture of C chauvoei |
Suspension for injection |
2- , 10- , 5- , 2.5- , 3.5- , 2.5- , 90- |
Inactivated Avian Influenza A virus strain H9N2 |
Emulsion for injection |
8-10- |
Pasteurella multocida antigen |
Suspension for injection |
10000Protection |
Clostridium Perfringens Type-D antigen |
Suspension for injection |
NLT 5IU |
Brucella abortus S 19 antigen |
Lyophilisate for suspension for injection |
0.3 to 3billion CFU |
Rabies antigen (CVS Strain) |
Solution for injection |
NLT 1IU |
Virus laryngotracheitidis contagiosae canis/ Parvovirus enteritidis canis/ Virus parainfluensis canis/ Leptospira icterohaemorrhagiae inactivated/ Leptospira canicola inactivated/Leptospira grippotyphosa inactivated/ Virus febris contagiosae canis |
Lyophilisate for suspension for injection |
10E3.5-4.5TCID50/dose , 10E4.5-5.5TCID50/dose , 10E3.0-4.2TCID50/dose , min. 32TCID50/dose , min. 32TCID50/dose , min. 32TCID50/dose , 10E3.0-4.5TCID50/dose |